Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2 Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer

NCT02953782 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02953782
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02953782 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2 Trial of Hu5F9-G4 in Combination With Cetuximab in Patients With Solid Tumors and Advanced Colorectal Cancer
Lead sponsor
Gilead Sciences
Phase
Phase 1/2
Overall status
Completed
Start date
November 2, 2016
Completion date
February 10, 2020
Enrollment
78 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, solid tumor